FWF I have been adding to my MRK w/ several small adds this year. My one new name is JNJ and it came up on all of my Value screens too. As a result have made a BIG bet on JNJ w/ several small buys begining this year.
JNJ is now 13th in my portfolio just 3 below AMAT. I got my avg cost down to $150.34/share and will add more at/below that price.
FWIW MRK is 17th largest holding but 87% of my shares were bought in 6/2009 at $26/share.
Also for these stocks > $150/share when I say small adds it is usually 5 shares (or about $1K/transaction).
---------------------------------------------------------------
I need to get w/ the times and make my average add $5K. I have missed a lot of buying opportiunities by not scaling up my Buys especially when the market has big sell offs.
I do like the Drug/Pharma and the medical devise sector. I still have a small position in ZBH which is also getting into Buy territory. I am being patient and only buying at/below $90 but will increase the size of those buys.
MDT another one I own but small but have my avg cost at $76 so only will add if this sell at/below that price and/or if the value metrics scream a buy.
The other name which has performed really well is MMM. All of my buys were in 2023 w/ an avg cost now at $79. MMM is selling at $150 so almost a double in 2 years. MMM has grown to #18 just below MRK and 4 below JNJ.
MMM not really a pure drug/pharma/medical devise play but look at their exposure to this sector:
Yes, 3M has significant exposure in both the pharmaceutical and medical device sectors.
In the Pharmaceutical Sector:
While 3M isn't a pharmaceutical manufacturer in the sense of developing and producing drugs, they are a crucial supplier to the industry. Their exposure primarily comes from:
- Personal Protective Equipment (PPE): 3M provides a wide range of health and safety solutions for pharmaceutical manufacturing, including respirators, protective clothing, hearing protection, and eyewear. These products safeguard workers from hazards like chemical exposure, respiratory risks, and noise during the handling of active pharmaceutical ingredients (APIs), cleaning, and disinfection processes.
- Industrial Solutions: 3M offers various industrial products used in pharmaceutical manufacturing, such as tapes for sealing and labeling, and other materials that support production and maintenance.
In the Medical Device Sector:
3M has a direct and extensive presence in the medical device sector. This includes:
- Medical Component Tapes & Films: 3M is a major supplier of specialized tapes, films, and adhesives used in the manufacturing of various medical devices. These components are critical for bonding, securing, and protecting medical device parts, including those with direct patient contact.
- Finished Medical Products: 3M manufactures and sells a range of medical products directly. These include:
- Wound Care: Bandages, dressings (e.g., Tegaderm), and advanced wound care solutions.
- Patient Care and Monitoring: Stethoscopes (Littmann brand), ECG electrodes, temperature management products, and port protectors.
- Surgical Supplies: Hand antiseptics, surgical scrubs, and antimicrobial incise drapes.
- Braces & Supports: Products under brands like FUTURO and ACE.
- Sterilization Assurance: Products for monitoring sterilization processes in healthcare settings.
- Other Medical Supplies: X-ray supplies, skin care products, and even animal recovery collars.
It's important to note that 3M recently spun off its healthcare business into a new standalone company called Solventum. This means that many of the direct medical products and solutions that were previously under 3M's umbrella are now part of Solventum. However, 3M still maintains its role as a supplier of industrial and PPE solutions to the broader healthcare and pharmaceutical industries.
They spun out SOLV - SOLVENTUM CORP in 2023 which I have built to a #26 position in the portfolio. Hope it will grow to the size of my other Pharma names. My avg cost is $56 (last price $75) and I would not be surprised to see this name doubel in 24-36 months.
---------------------------------------------------------------------------------
So the best name in the group over the last 3-5 years could be MMM (along w/ the SOLV spin off). Look at some of the hidden assets in these larger names, especially their spin offs.
IBM spun off KD (2023) and KD was a dog for the first 15 months but now is one of my largest gainers. My average cost is $10/share and continue to peel off shares (sold some today at $42.50/share).
LLY has an excellent pipeline but too expensive for me. |